Microscale to manufacturing scale-up of cell-free cytokine production: A new approach for shortening protein production development timelines
Taking advantage of these resources before considering peptide use establishes baseline health status and increases confidence that no occult malignancy exists
Determinants of riboflavin responsiveness in multiple acyl-CoA dehydrogenase deficiency
doi: 10.3389/fphar.2023.1187797 Received 16 March 2023 Accepted 25 October 2023 Published 13 November 2023 Volume 14 - 2023 Edited by Runyue Huang, Guangzhou University of Chinese Medicine, China Reviewed by Cong-En Zhang, Capital Medical University, China Guangrui Huang, Beijing University of Chinese Medicine, China Updates Copyright 2023 Xu, Peng, Ma, Xie, Li, Wang, Guo, Nan, Wang, Li, Xu and Gong